Influence of the B cell receptor (BCR) signaling pathways on CD20 levels in tumor cells and antitumor activity of anti-CD20 monclonal antibodies

2012/07/B/NZ6/03498

Keywords

Descriptors

  • NZ6_8: Inne zagadnienia pokrewne
  • NZ6_2: Immunologia kliniczna

Panel

NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology

Host institution

Warszawski Uniwersytet Medyczny, I Wydział Lekarski

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Magdalena Winiarska

Number of co-investigators in the project: 5

Call

OPUS 4 – announced on 2012-09-15

Amount awarded
786 000 PLN
Project start date
2013-06-20
Project end date
2016-06-19
Project duration
36 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. kompaktowy cytometr. Cost: 190 000 PLN
  2. Ława do przygotowania reakcji PCR. Cost: 20 000 PLN

Information in the final report

Publication in academic press/journals (5)

  1. Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulating proteins

    Authors:
    Michal Dwojak, Malgorzata Bobrowicz, Jacek Bil, Kamil Bojarczuk, Beata Pyrzynska, Marta Siernicka, Agata Malenda, Ewa Lech-Maranda, Waldemar Tomczak, Krzysztof Giannopoulos, Jakub Golab, Magdalena Winiarska
    Academic press:
    Blood Cancer Journal (year: 2015, volume: 46122, pages: e300), Publisher: Nature Publishing Group
    Status:
    Published
    DOI:
    10.1038/bcj.2015.27 – link to the publication
  2. B-cell receptor signaling in the pathogenesis of lymphoid malignancies

    Authors:
    Kamil Bojarczuk, Malgorzata Bobrowicz, Michal Dwojak, Nina Miazek, Piotr Zapala , Anders Bunes , Marta Siernicka , Maria Różanska, Magdalena Winiarska
    Academic press:
    Blood Cells Mol Dis (year: 2015, volume: Oct;55(3), pages: 255-65), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bcmd.2015.06.016. – link to the publication
  3. Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells

    Authors:
    Siernicka M, Winiarska M, Bajor M, Firczuk M, Muchowicz A, Bobrowicz M, Fauriat C, Golab J, Olive D, Zagozdzon R
    Academic press:
    Immunology (year: 2015, volume: Sep;146(1), pages: 173-83), Publisher: John Wiley & Sons
    Status:
    Published
    DOI:
    10.1111/imm.12494 – link to the publication
  4. B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies

    Authors:
    Kamil Bojarczuk, Marta Siernicka, Michal Dwojak, Malgorzata Bobrowicz, Beata Pyrzynska, Pawel Gaj, Marta Karp, Krzysztof Giannopoulos, Dimitar G Efremov, Cyril Fauriat, Jakub Golab, Magdalena Winiarska
    Academic press:
    Leukemia (year: 2014, volume: 5, pages: 1163-1167), Publisher: American Society of Hematology
    Status:
    Published
    DOI:
    10.1038/leu.2014.12 – link to the publication
  5. Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies

    Authors:
    Magdalena Winiarska, Kamil Bojarczuk, Beata Pyrzynska, Jacek Bil, Marta Siernicka, Michal Dwojak, Malgorzata Bobrowicz, Nina Miazek, Piotr Zapala, Agnieszka Zagozdzon, Magdalena Krol, Aleksandra Syta, Paulina Podszywalow-Bartnicka, Zofia Pilch, Anna Dabrowska-Iwanicka, Przemyslaw Juszczynski, Dimitar G Efremov, Mikolaj Slabicki, Thorsten Zenz, Aude Le Roy, Daniel Olive, Tomasz P Rygiel, Jeanette HW Leusen, Jakub Golab
    Academic press:
    mAbs (year: 2014, volume: 5, pages: 1300-1313), Publisher: Taylor & Francis Group
    Status:
    Published
    DOI:
    10.4161/mabs.32106 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski